Q1 European Cannabis Industry Update Report

While the American cannabis industry deals with both unparalleled opportunity and new risks, Europe is setting itself up for a spring that is going to be verdant. The ongoing drumbeat for reform in countries across the continent is bringing both money and high-grade medical product into the market. Even if […]

European Cannabis News Roundup- Summer 2017

Obstacles to American cannabis reform are creating a quirky if valuable market. Cannabis is still a “Schedule I” drug. From a practical perspective, this has created a multi-billion dollar industry that as of yet, cannot get reliable banking services. It also means that patients cannot get the drug covered under […]